Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 500 entries
View as:

Vytorin Reexamination Study (0653A-174)

Phase: N/A Priority: Normal
NCT ID: NCT01070966 Org: User:
Start: 07/31/05 End: 04/30/10 Due: 04/30/11

Montelukast in Chronic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00802789 Org: User:
Start: 04/30/07 End: 10/31/08 Due: 10/31/09

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)

Phase: N/A Priority: Normal
NCT ID: NCT01244815 Org: User:
Start: 06/16/11 End: 09/17/13 Due: 09/17/14

A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)

Phase: N/A Priority: Normal
NCT ID: NCT02460159 Org: User:
Start: 06/23/15 End: 12/22/16 Due: 12/22/17

Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)

Phase: N/A Priority: Normal
NCT ID: NCT00396175 Org: User:
Start: 03/31/98 End: - Due: -

A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1)

Phase: N/A Priority: Normal
NCT ID: NCT00604500 Org: User:
Start: 03/01/08 End: 11/01/08 Due: 11/01/09

Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)

Phase: N/A Priority: Normal
NCT ID: NCT00756938 Org: User:
Start: 03/01/09 End: 08/14/12 Due: 08/14/13

3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)

Phase: N/A Priority: Normal
NCT ID: NCT00159744 Org: User:
Start: 11/30/04 End: 04/29/06 Due: 04/29/07

Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)

Phase: N/A Priority: Normal
NCT ID: NCT00653835 Org: User:
Start: 09/01/03 End: 08/01/04 Due: 08/01/05

Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05172726 Org: User:
Start: 12/02/21 End: 09/30/26 Due: 09/30/27

Post-Marketing Surveillance of the Safety and Efficacy of Orgalutran (Ganirelix)®

Phase: N/A Priority: Normal
NCT ID: NCT01304511 Org: User:
Start: 02/28/05 End: 12/31/07 Due: 12/31/08

Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)

Phase: N/A Priority: Normal
NCT ID: NCT00092742 Org: User:
Start: 02/28/03 End: 12/31/05 Due: 12/31/06

Study of the Bioequivalence of the 20% and 30% Etoricoxib Tablet Formulations (0663-070)

Phase: N/A Priority: Normal
NCT ID: NCT00945035 Org: User:
Start: 11/30/02 End: 12/31/02 Due: 12/31/03

Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520)

Phase: N/A Priority: Normal
NCT ID: NCT01852812 Org: User:
Start: 06/07/13 End: 12/24/13 Due: 12/24/14

Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)

Phase: N/A Priority: Normal
NCT ID: NCT00702273 Org: User:
Start: 04/19/06 End: 05/31/09 Due: 05/31/10

LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00496834 Org: User:
Start: 02/01/08 End: 09/01/09 Due: 09/01/10

6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777)

Phase: N/A Priority: Normal
NCT ID: NCT00265343 Org: User:
Start: 12/31/05 End: 01/31/08 Due: 01/31/09

Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)

Phase: N/A Priority: Normal
NCT ID: NCT01190254 Org: User:
Start: 09/28/10 End: 04/01/13 Due: 04/01/14

A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)

Phase: N/A Priority: Normal
NCT ID: NCT00140946 Org: User:
Start: 03/31/98 End: 10/31/00 Due: 10/31/01

Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00140959 Org: User:
Start: 02/01/03 End: 06/30/04 Due: 06/30/05

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)

Phase: N/A Priority: Normal
NCT ID: NCT00703014 Org: User:
Start: 07/13/06 End: 03/15/09 Due: 03/15/10

A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)

Phase: N/A Priority: Normal
NCT ID: NCT02741245 Org: User:
Start: 06/09/16 End: 01/18/17 Due: 01/18/18

Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464)

Phase: N/A Priority: Normal
NCT ID: NCT00730132 Org: User:
Start: 01/31/08 End: 08/31/09 Due: 08/31/10

A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)

Phase: N/A Priority: Normal
NCT ID: NCT00092040 Org: User:
Start: 03/18/03 End: 09/28/05 Due: 09/28/06

Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994)

Phase: N/A Priority: Normal
NCT ID: NCT00757562 Org: User:
Start: 11/01/02 End: 10/01/03 Due: 10/01/04